Aptinyx News


Keine aktuellen Kursdaten verfügbar

ISIN: US03836N1037

US-Symbol: APTX

Typ: Aktie

Aptinyx News

11.06.21 - PR Newswire

Thinking about buying stock in Vaxart, Graybug Vision, Jaguar Health, iBio, or Aptinyx?

Thinking about buying stock in Vaxart, Graybug Vision, Jaguar Health, iBio, or Aptinyx? PR Newswire

20.10.20 - PR Newswire

Thinking about buying stock in Aptinyx, Acorda Therapeutics, T-Mobile, Best Buy, or Advanced Micro Devices?

Thinking about buying stock in Aptinyx, Acorda Therapeutics, T-Mobile, Best Buy, or Advanced Micro Devices? PR Newswire

10.10.19 - PR Newswire

Lifshitz & Miller LLP Announces Investigation of Abeona Therapeutics Inc., Aptinyx Inc., James River Group Holdings, Ltd., The Chemours Company, Overstock.com, Inc., Greenland Acquisition Corporation and Wanda Sports Group Limited

Lifshitz & Miller LLP Announces Investigation of Abeona Therapeutics Inc., Aptinyx Inc., James River Group Holdings, Ltd., The Chemours Company, Overstock.com, Inc., Greenland ...

08.10.19 - PR Newswire

Aptinyx (APTX) Alert: Johnson Fistel Launches Investigation into Aptinyx Inc.; Investors Suffering Losses Encouraged to Contact Firm

Aptinyx (APTX) Alert: Johnson Fistel Launches Investigation into Aptinyx Inc.; Investors Suffering Losses Encouraged to Contact Firm PR Newswire

25.06.18 - PR Newswire

Aptinyx Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Aptinyx Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares PR Newswire

Newssuche

Videos

26.04.24 +6,31%

Technical Trading: Gold Long freitags

Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »

Biotech-Einhorn!

FDA Zulassung für das CBD-Wunder?!
weiterlesen»

Anzeige